Buprenorphine and Naloxone Clinical Pharmacology Abuse …丁丙诺啡和纳洛酮的临床药理学的滥用….ppt

Buprenorphine and Naloxone Clinical Pharmacology Abuse …丁丙诺啡和纳洛酮的临床药理学的滥用….ppt

  1. 1、本文档共76页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Buprenorphine and Naloxone Clinical Pharmacology Abuse …丁丙诺啡和纳洛酮的临床药理学的滥用…

Buprenorphine and Naloxone: Clinical Pharmacology Abuse Liability John Mendelson MD California Pacific Medical Research Institute and the University of California at San Francisco Presentation Goals Review Buprenorphine Pharmacology Basic Pharmacology Sublingual pharmacokinetics Review Rational for Suboxone (Buprenorphine Naloxone combo tablet) Predicted effects in Buprenorphine treated patients MMT patients Untreated Heroin Addicts Onward Review Buprenorphine Pharmacology Basic Pharmacology Sublingual pharmacokinetics Review Rational for Suboxone (Buprenorphine Naloxone combo tablet) Predicted effects in Buprenorphine treated patients MMT patients Untreated Heroin Addicts Buprenorphine Pharmacology Semisynthetic, highly lipophylic Thebaine derivative 25 to 50 times more potent than morphine Partial μ-agonist Some kappa antagonist effects Clinical significance unclear Pharmacotherapy with Buprenorphine Used as parenteral analgesic in Europe (1o England) for cancer pain and in obstetrics Never caught on in USA May produce less respiratory depression than traditional μ-agonists Analgesia Buprenorphine vs. Morphine 0.4 mg Buprenorphine IM equianalgesic with 10 mg Morphine IM Analgesia lasts longer (6 hours) Maximal effects occur later Peak respiratory depression at 3 hours Peak miosis at 6 hours Pharmacological Properties Partial agonist effects suggested by Ceiling on analgesic effects Antagonizes fentanyl induced respiratory depression without complete loss of anesthesia Indicates high affinity for μ-receptor Can precipitate opiate withdrawal in highly μ-dependent people Advantages of Buprenorphine Tolerable dose range (4 to 32 mg SL daily to every 3rd day) for addiction pharmacotherapy Partial agonist Ceiling effects so safer in overdose Less/absent effects in μ-dependent addicts Kappa antagonist Less euphoria Disadvantages of Buprenorphine Can be abused Risk may be greatest in new abusers Is only a partial agonist not suitable for addicts with high

文档评论(0)

ctuorn0371 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档